CnU Cap. 500 mg

· Myungmoon Pharma Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CnU Cap. 500 mg, covering 2025-10-02 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia [Phase 4]